SOURCES SOUGHT
A -- Purchase of Cardiomyocytes
- Notice Date
- 12/1/2011
- Notice Type
- Sources Sought
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, Bldg 50 Room 422, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 1097919
- Archive Date
- 12/24/2011
- Point of Contact
- Marcia O Park, Phone: (870) 543-7405
- E-Mail Address
-
marcia.park@fda.hhs.gov
(marcia.park@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- This notice is for Market Research purposes only, not a request for quotations or solicitation. The Food and Drug Administration (FDA) is seeking sources, including service-disabled veteran-owned small businesses, HUBzone small business, 8(a) certified small businesses, woman owned small businesses, small disadvantaged businesses as well as small businesses. The following information is provided to assist the FDA in conducting Market Research to identify potential contractor for providing the items below. All parties may respond to this synopsis. The North American Industry Classification System (NAICS) code is 541711 - Research and Development in Biotechnology with a small business size standard of 500 employees. Project Background The FDA/National Center for Toxicological Research (NCTR) has been tasked with conducting various in vitro (cell culture) omics studies to support the Center for Tobacco Products (CTP) regulatory mission. As a part of these studies, testing of different tobacco products for their relative toxicity in heart muscle cells is required in order to mimic human cardiovascular effects from smoking. Therefore, large scale pluripotent-stem cell derived cardiomyocytes (as opposed to immortal cells or human primary cells) are required for toxicity testing since they have all the properties of a cardiomyocyte, exhibit a stable phenotype and can be supplied in large quantities (i.e., 23 units). Funding for this project is contingent upon the availability of Fiscal Year 2012 funds. Potential contractors must indicate business size, proof of any set-aside certification and company's DUNS number and provide a contact name, the mailing address, phone number and email address of point of contact. Capability statement must provide enough information to determine if company can meet requirements stated above by including technical specifications, descriptive literature, brochures and other information that demonstrates the capabilities of the contractor to meet the requirements. Provide two contact names, email and phone numbers for user of the proposed product that may be contacted by the Government. Identify availability under GSA contract if applicable. Potential contractors proposing a product manufactured by a small business must certify that the product is manufactured by a small business and provide the name and DUNS number of that small business manufacturer. Responses are due in person, by postal mail or by email to the point of contact listed below on or before December 9, 2011 by 1:00 P.M. CST at the Food and Drug Administration, OC/OA/OAGS, Attn: Marcia Park, 3900 NCTR Road, HFT-322, Jefferson, AR 72079-9502. Reference 1097919. Questions regarding this posting shall be submitted via email no later than 1:00 P.M. CST on December 7, 2011. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to user information provided by the respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to provide the product specified. Respondents are advised the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a solicitation may be published in the Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. No proprietary, classified, confidential or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in a resultant solicitation that may result from this market survey. For information regarding this notice, contact Marcia Park, 870/543-7405, FAX 870/543-7990 or email Marcia.park@fda.hhs.gov.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/1097919/listing.html)
- Place of Performance
- Address: Food and Drug Administration/National Center for Toxicological Research, 3900 NCTR Road, Jefferson, Arkansas, 72079, United States
- Zip Code: 72079
- Zip Code: 72079
- Record
- SN02631715-W 20111203/111201234725-26e362b9c25dea07b227226ac3d8d53d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |